Cargando…
Chaetoglobosin E inhibits tumor growth and promotes the anti-tumor efficacy of cytotoxic drugs in esophageal squamous cell carcinoma by targeting PLK1
BACKGROUND: Currently, there is no satisfactory treatment available for esophageal squamous cell carcinoma (ESCC), and thus, there is a pressing need to develop effective drugs. Chaetoglobosin E, a cytochalasan alkaloid derived from metabolites of Chaetomium madrasense 375, is a chaetoglobosin with...
Autores principales: | Chen, Jin-Hua, Guo, Qing-Feng, Liu, Qiu-Ge, He, Bao-Xia, Song, Wen-Ping, Yin, Zhen-Hua, Li, Dong-Bei, Chen, Lin, Zhang, Wen-Zhou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761161/ https://www.ncbi.nlm.nih.gov/pubmed/36544631 http://dx.doi.org/10.21037/atm-22-5320 |
Ejemplares similares
-
Bioactivities and Future Perspectives of Chaetoglobosins
por: Chen, Jinhua, et al.
Publicado: (2020) -
Bioactive Chaetoglobosins from the Mangrove Endophytic Fungus Penicillium chrysogenum
por: Huang, Song, et al.
Publicado: (2016) -
New production process of the antifungal chaetoglobosin A using cornstalks
por: Jiang, Cheng, et al.
Publicado: (2017) -
HN1L/AP-2γ/PLK1 signaling drives tumor progression and chemotherapy resistance in esophageal squamous cell carcinoma
por: Zeng, Ting-Ting, et al.
Publicado: (2022) -
Diagnostically analyzing (1)H NMR spectra of sub-types in chaetoglobosins for dereplication
por: Lin, Chen, et al.
Publicado: (2020)